Product Overview

Femafill 100 mg is a prescription‑strength oral tablet that contains Sildenafil Citrate, a phosphodiesterase type 5 (PDE5) inhibitor that has been extensively studied for its ability to enhance blood flow in genital tissues. Manufactured by Cinala Wellness, each strip houses four film‑coated tablets, each delivering a precise 100 mg dose of the active ingredient. The product is packaged in a range of supply options — 60, 120, 180, or 240 tablets — allowing patients to select the quantity that best matches their treatment plan and insurance coverage. Shipment typically occurs within six to fifteen calendar days, depending on the selected delivery method and destination. This overview presents a comprehensive, medically responsible summary of the medication, its therapeutic indication for female sexual dysfunction, and practical information regarding storage, handling, and regulatory compliance.

What is Femafill 100 Mg (Sildenafil Citrate)

Sildenafil Citrate represents the same pharmacologically active compound that is widely recognized in the treatment of male erectile dysfunction, and it functions by potentiating the nitric oxide‑cGMP signaling cascade within vascular smooth muscle cells. In the female population, this biochemical effect can lead to increased arterial inflow to the clitoral corpora and vaginal mucosa, facilitating engorgement and natural lubrication when sexual arousal is present. Femafill 100 mg is formulated specifically for women who experience persistent difficulty achieving or maintaining adequate sexual response. The tablets are produced under the same stringent manufacturing practices required by the U.S. Food and Drug Administration (FDA), ensuring consistent potency and purity. Although the drug is not universally labeled for female indications, a growing body of peer‑reviewed research and systematic reviews has examined its efficacy and safety in controlled clinical trials, providing a scientific basis for off‑label prescribing under the supervision of a qualified healthcare professional (see National Institutes of Health).

Uses and Benefits

The therapeutic objective of Femafill 100 mg is to mitigate the symptoms of female sexual arousal disorder, which may manifest as inadequate vaginal lubrication, diminished clitoral sensation, or reduced orgasmic intensity. When integrated into a holistic sexual health strategy, the medication can help restore confidence, enhance pleasure, and improve overall intimate relationship satisfaction. The strip‑based packaging contains four tablets, offering a discreet and portable solution that reduces the frequency of pharmacy visits and supports spontaneous sexual activity. Available in pack sizes of 60, 120, 180, or 240 tablets, Femafill enables patients to tailor their supply to the anticipated duration of treatment while potentially achieving cost savings through bulk purchasing. For clinicians, the fixed 100 mg strength simplifies dosing regimens and minimizes the risk of dosing errors that are more common with variable‑strength formulations.

How It Works

Pharmacodynamically, Sildenafil Citrate inhibits phosphodiesterase type 5, an enzyme responsible for hydrolyzing cyclic guanosine monophosphate (cGMP) in smooth muscle cells. Inhibition results in elevated intracellular cGMP levels, which promotes relaxation of vascular smooth muscle and subsequent vasodilation. In genital tissues, this mechanism translates into increased blood flow to the clitoral bodies and vaginal walls, facilitating engorgement and enhancing the transudation of lubricating fluids. The onset of action typically occurs within thirty to sixty minutes after oral ingestion, with a duration of effect that may extend up to four hours, thereby providing a practical window for spontaneous intimacy. The pharmacokinetic profile is influenced by factors such as food intake, hepatic metabolism, and concomitant medications, all of which should be considered when determining the optimal timing of administration.

Dosage Guidelines

Patients are generally advised to take one Femafill 100 mg tablet orally with a full glass of water approximately one hour before anticipated sexual activity. The tablet may be consumed with or without food; however, a high‑fat meal can delay absorption and reduce peak plasma concentrations, potentially diminishing efficacy. The maximum recommended frequency is once every 24 hours, and the total daily dose should not exceed 100 mg unless a physician explicitly directs otherwise. Individuals with hepatic impairment, renal dysfunction, or those taking medications that influence the cytochrome P450 enzyme system may require dose adjustment or an extended dosing interval to avoid accumulation and potential toxicity. It is imperative that patients do not alter the prescribed dose without consulting a healthcare provider and that Femafill is not used in combination with other PDE5 inhibitors, nitrates, or alpha‑blockers without medical supervision, as such combinations can precipitate unsafe reductions in blood pressure.

Side Effects

Adverse reactions associated with Femafill 100 mg are generally mild and transient, reflecting the drug’s favorable safety profile when used as directed. The most frequently reported side effects include headache, facial flushing, nasal congestion, and mild gastrointestinal discomfort such as dyspepsia. Visual disturbances — such as transient blurred vision or a temporary blue‑tinted perception — may also occur, typically resolving spontaneously once the drug is cleared from the system. Although rare, more serious complications can include priapism (a persistent erection lasting longer than four hours), sudden hearing loss, or cardiovascular events in patients with pre‑existing cardiac conditions. Should any of these severe symptoms manifest, immediate medical attention is recommended. A comprehensive list of possible side effects is documented in the product’s prescribing information and can be reviewed for additional detail (MedlinePlus).

Warnings and Precautions

Femafill is contraindicated in patients who have a known hypersensitivity to Sildenafil Citrate or any of the excipients present in the tablet formulation. Caution should be exercised in individuals with severe cardiovascular disease, uncontrolled hypertension, recent cerebrovascular accident, or recent myocardial infarction, as the vasodilatory effect may exacerbate hemodynamic instability. Concomitant use with nitric oxide donors, nitrates, or certain anti‑arrhythmic agents is strictly prohibited due to the risk of profound hypotension. Pregnant or lactating women should avoid the medication unless a physician determines that the potential therapeutic benefit justifies the possible risk to the fetus or infant. Patients with moderate to severe hepatic or renal impairment may require dose modification, and routine monitoring of liver and kidney function is advisable in such cases. Proper storage at room temperature, away from moisture and direct sunlight, helps preserve tablet integrity and potency. Finally, the medication must be kept out of reach of children and pets to prevent accidental ingestion.

Frequently Asked Questions

Related Products

• Femalegra 100 mg (Female Viagra)(Sildenafil Citrate)
• Extra Super Enjofil (Sildenafil/Dapoxetine)
• Varda Power (Vardenafil/Dapoxetine)
• Super Enjofil 160 Mg (Sildenafil/Dapoxetine)
• Varda Super Power (Vardenafil/Dapoxetine)
• Charam Spray 20ml (Sildenafil Citrate)
• Extra Super Nitfire 100 Mg (Tadalafil/Dapoxetine)
• Shakti Enjofil (Sildenafil/Dapoxetine)
• Hiforce FM (Sildenafil)